Filing Details

Accession Number:
0001181431-10-005944
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-02 12:00:00
Reporting Period:
2010-02-01
Filing Date:
2010-02-02
Accepted Time:
2010-02-02 16:02:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1040416 Inspire Pharmaceuticals Inc ISPH Pharmaceutical Preparations (2834) 043209022
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1145910 R Benjamin Yerxa C/O Inspire Pharmaceuticals, Inc.
4222 Emperor Blvd., Suite 200
Durham NC 27703
Evp & Chf, Research & Develop No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-02-01 200 $5.46 60,057 No 4 S Direct
Common Stock Disposition 2010-02-01 100 $5.44 59,957 No 4 S Direct
Common Stock Disposition 2010-02-01 45 $5.43 59,912 No 4 S Direct
Common Stock Disposition 2010-02-01 455 $5.41 59,457 No 4 S Direct
Common Stock Disposition 2010-02-01 1,200 $5.40 58,257 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Sales Plan Agreement adopted by the Reporting Person on June 3, 2009.